Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug;39(8):2853-2860.
doi: 10.1007/s00345-021-03589-6. Epub 2021 Jan 22.

Contrast-enhanced ultrasound (CEUS) imaging for active surveillance of small renal masses

Affiliations

Contrast-enhanced ultrasound (CEUS) imaging for active surveillance of small renal masses

Elena Bertelli et al. World J Urol. 2021 Aug.

Abstract

Purpose: To assess the safety and efficacy of contrast-enhanced ultrasound (CEUS) imaging for monitoring small (< 4 cm) renal masses (SRM) in patients undergoing active surveillance (AS).

Methods: We retrospectively selected all consecutive patients with SRMs who underwent AS for at least 6 months at our Institution between January 2014 and December 2018. CEUS imaging was performed by two experienced genitourinary radiologists at established time points. The accuracy of CEUS for monitoring SRM size was compared with that of CT scan. For solid SRMs, four enhancement patterns (EP) were recorded. Radiological progression was defined as SRM growth rate ≥ 5 mm/year.

Results: Overall, 158/1049 (15.1%) patients with SRMs underwent AS. At a median follow-up of 25 months (IQR 13-39), no patient died due to renal cell carcinoma (RCC). No patients experienced CEUS-related adverse events. There was a large variability in the pattern of growth of SRMs (overall median growth rate: 0.40 mm/year), with 9.5% of SRMs showing radiological progression. The median SRM size was comparable between CEUS and CT scan examinations at all time points. The vast majority (92.7%) of SRMs did not show a change in their EP over time; and there was no association between the SRM's EP and radiological progression or SRM size. Overall, 43 (27.2%) patients underwent delayed intervention (DI); median SRM size, and median growth rate were significantly higher in these patients as compared to those continuing AS.

Conclusion: In experienced hands, CEUS is a safe and effective strategy for active monitoring of SRMs in well-selected patients undergoing AS.

Keywords: Active surveillance; Contrast-enhanced ultrasound (CEUS); Cyst; Renal neoplasm; Small renal mass.

PubMed Disclaimer

References

    1. Capitanio U, Bensalah K, Bex A et al (2019) Epidemiology of renal cell carcinoma. Eur Urol 75(1):74–84. https://doi.org/10.1016/j.eururo.2018.08.036 - DOI - PubMed
    1. Mir MC, Capitanio U, Bertolo R et al (2018) Role of active surveillance for localized small renal masses. Eur Urol Oncol 1(3):177–187. https://doi.org/10.1016/j.euo.2018.05.001 - DOI - PubMed
    1. Finelli A, Ismaila N, Bro B et al (2017) Management of small renal masses: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 35(6):668–680. https://doi.org/10.1200/JCO.2016.69.9645 - DOI - PubMed
    1. Cheaib JG, Pierorazio PM (2019) How does treatment uncertainty factor into decisions to place patients on active surveillance for kidney cancer? Eur Urol Focus 5(6):946–948. https://doi.org/10.1016/j.euf.2019.07.002 - DOI - PubMed
    1. Campbell S, Uzzo RG, Allaf ME et al (2017) Renal mass and localized renal cancer: AUA guideline. J Urol 198:520–529. https://doi.org/10.1016/j.juro.2017.04.100 - DOI - PubMed

MeSH terms